South Africa aims to detect every TB patient, while a million cases in India slip through the cracks
South Africa has launched one of the most progressive TB screening campaigns in the world. Budget cuts have nearly derailed India's TB programme.
This year on March 24, on the occasion of World Tuberculosis
Day, global attention was sharply drawn towards the disease when
British Prime Minister David Cameron launched a report by an
expert panel on anti-microbial resistance. The outlook was dire
– over the next 35 years, 75 million people are likely to
lose their lives to drug resistant TB, and by 2050, the
infection could cost the global economy as much as $17
trillion.
On the same day, half way across the world
in a small gold mining town called Kanana in the North West
Province of South Africa, the nation’s Health Minister
Aaron Motsoaledi launched one of the most progressive TB
screening campaigns in the world. Kanana is the birthplace of
Nobel Prize laureate and TB survivor Archbishop Desmond Tutu.
South
Africa’s TB epidemic is the third largest in the world
behind India and China. The five-year-long campaign
called Ending South Africa's TB epidemic: Accelerating our Response
in Key Populations aims to ensure that at least 90% of vulnerable populations are
screened for TB, at least 90% of all cases are diagnosed, and to
ensure at least 90% access to treatment.
“In
October last year, there was an international lung conference in
Barcelona in Spain," said Health Minister Aaron Motsoaledi in an
exclusive interview to Scroll. "We had just
come back from Melbourne where the International AIDS conference
had adopted 90-90-90 for HIV AIDS. So, when I was in Barcelona
for the international lung conference, I said that it would be
unfair for the world to adopt 90-90-90 for HIV-AIDS, and not do
the same for TB, especially in Africa where the
co-infection rate is so high. I said, let's do the same thing
for TB.”
To that end, South Africa has
identified groups that are most at risk, including the
country’s 150,000 men and women in correctional
facilities, over 500,000 miners, and nearly 5.1 million people
in six high risk areas. Over the next few months, and perhaps
longer, each one of these people will not just be screened for
TB but also offered treatment and care. In addition, children
will receive special attention and will be tested in Early
Childhood Development Centres. The clear aim of the campaign is
to reduce the number of TB related deaths in South Africa from
1,20,000 to 20,000 per year. The campaign will last until 2017
and will target six mining districts in four provinces.
In
a statement, Dr Lucica Ditiu, Executive Secretary of Stop
TB Partnership said: “The country's national strategic
plan is hugely ambitious with a call for all South Africans to
be screened for TB at least once a year. This is a bold step in
the direction of moving from just saving the dying to a state of
'keeping the population healthy and devoid of TB."
According
to the World Health Organisation, there are 530,000 new
infections each year in South Africa. Nearly 66% of those new
infections are people who are co-infected with HIV and TB. In
the last 15 years, TB incidence in the country has risen by
400%.
South Africa’s new TB screening campaign
has far reaching implications for the developing world,
particularly the BRICS nations, in diagnosing and treating the
disease.
“Within BRICS, we constantly learn
from each other’s experiences, strengths and weaknesses.
For instance, we are learning technology transfer from India at
the moment. Similarly, I spoke to the Minister of Health in
India in May about applying the 90-90-90 vision for TB, and
we have decided to adopt stricter measures,” Dr.
Motsoaledi said.
India's TB programme
While South African TB programme is combing through
high risk populations to not let a single person go undetected,
India's programme is almost derailing.
According to
data presented by the government in the Lok Sabha last month,
India had 2.6 million cases of tuberculosis as per the latest
count and ranks 14th among 22 high TB burden countries. Further,
an estimated 61,000 MDR-TB cases have been reported.
But
the numbers could be higher. A leaked report
by the Joint Monitoring Mission of the Revised National
Tuberculosis Control Programme which assessed India's National
Tuberculosis policy has noted that nearly a million people
living with tuberculosis in the country have either gone
undiagnosed or unreported.
The spread of tuberculosis
in India, particularly of the drug-resistant kind, is fast
becoming a global concern. In April this year, an Indian woman
flew to O’Hare International Airport in Chicago. As per
the woman's travel documents, she visited relatives in Illinois,
Tennessee and Missouri before realising that she needed medical
attention to treat 'extensively drug-resistant tuberculosis', or
XDR-TB. The US authorities immediately informed the health
department and the Centers for Disease Control and
Prevention and began the gruelling drill of tracing down
everyone she had come in contact with across three states. As
New York Times
reported, the patient from India was transferred to the National
Institute of Health in Bethesda where she is seeking
treatment.
This case is a perfect example of how a
cash-strapped TB programme in India can have global
repercussions. In the past decade, India's TB programme has
screened over 80 million people, and treated and detected nearly
15 million patients. However, instead of investing in expansion
of the programme, budget cuts are threatening the future of TB
prevention in India.
“While RNTCP [Revised
National Tuberculosis Control Programme] expenditure has
increased 27% since 2012, there is a growing gap between the
allocation of funds and the minimum investment required to reach
the goals of the Plan," said the leaked JMM report. It warned
that if the trend continues, final expenditure on the plan would
fall to Rs. 3,000 crores, or two-thirds of the minimum required,
with 40% of the budget spent on treatment alone. "This threatens
the future of TB control in India and underscores the necessity
to prevent drug resistance,” it said.
Source:
Scroll.in